...Kalytera's CBD prevents graft-vs-host disease Kalytera Therapeutics Inc. (TSX-V:KLY; OTCQB:KALTF) announced plans to start a Phase III registrational...
...and Karen Tkach Tuzman, Associate Editor ABSK021 Cannabidiol (CBD) oral solution (cannabidiol) Abbisko Therapeutics Co. Ltd. Brigham and Women's Hospital Kalytera Therapeutics Inc. Colony-stimulating...

...as CFO. He was CFO at Bibby Offshore Holdings Ltd. (Aberdeen, U.K.). Cannabinoid therapeutics company Kalytera Therapeutics Inc....

...president and CEO. He was CEO of Thrasos Therapeutics Inc. (Montreal, Quebec). Cannabinoid therapeutics company Kalytera Therapeutics Inc....

...CBD) oral solution Insys Therapeutics Inc. (NASDAQ:INSY) Hyperphagic behavior leading to obesity Phase II KAL671 Kalytera Therapeutics Inc....

...On Feb. 17, cannabinoid therapeutics company Kalytera Therapeutics Inc. (TSX-V:KALY) raised C$1.6 million ($1.2 million) through the sale...
...million). Clarus Securities, Haywood Securities and Canaccord Genuity were placement agents. Kalytera Therapeutics Inc. (TSX-V:KALY), Beverly, Mass. Alicia Parker Kalytera Therapeutics Inc....